Kindly Md, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

Nakamoto Inc. is seeking stockholder approval for a reverse stock split of its common stock at a ratio between 1-for-20 and 1-for-50 to regain Nasdaq listing compliance.
Kindly MD, Inc. announced its 2025 Annual Meeting of Shareholders to vote on director elections, a corporate reincorporation to Delaware, and auditor ratification.
Kindly MD, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on December 17, 2025, to vote on director elections, corporate reincorporation, auditor ratification, and meeting adjournment.
Kindly MD, Inc. is holding its 2025 Annual Meeting to vote on key proposals including the re-election of directors, a strategic conversion to a Delaware corporation, and the ratification of its independent auditor.
Kindly MD, Inc. is set to merge with Nakamoto Holdings Inc., fundamentally shifting its business focus from healthcare to a bitcoin treasury strategy, backed by over $763 million in new equity and debt financing.
KindlyMD is holding its annual stockholder meeting on November 8, 2024, to re-elect its five directors and ratify the selection of Sadler Gibb & Associates as its independent accounting firm.